Skip to main content
Clinical Trials/NL-OMON21245
NL-OMON21245
Completed
未知

ongitudinal Monitoring of Neuropsychological Outcomes in Pediatric Oncology

The Princess Máxima Centre0 sites320 target enrollmentStarted: TBDLast updated:

Overview

Phase
未知
Status
Completed
Sponsor
The Princess Máxima Centre
Enrollment
320

Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational non invasive

Eligibility Criteria

Ages
2 to 17 (—)

Inclusion Criteria

  • New primary diagnosis of brain tumor, other solid tumor, or hemato\-oncological condition • Age between 6 and 18 years old at diagnosis • Followed at the Princess Máxima Centre for Pediatric Oncology

Exclusion Criteria

  • No signed informed consent • Insufficient knowledge of the Dutch language to perform the neuropsychological assessment or complete questionnaires • Significant visual, motor, or developmental problems and thus alternative neuropsychological assessments would be needed (i.e., blindness, deafness, profound developmental delay) • Patients receiving palliative therapy or end\-of\-life care • Treating physician advises against inclusion

Investigators

Sponsor
The Princess Máxima Centre

Similar Trials